REATA PHARMACEUTICALS INC Increase (Decrease) in Accounts Receivable
REATA PHARMACEUTICALS INC reported Increase (Decrease) in Accounts Receivable of $22.66 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2023-08-08
- 2023-06-30: Increase (Decrease) in Accounts Receivable 6 month $22.66M.
- 2022-06-30: Increase (Decrease) in Accounts Receivable 6 month $0.00.
- 2016-06-30: Increase (Decrease) in Accounts Receivable 6 month $735.00K.
- 2015-06-30: Increase (Decrease) in Accounts Receivable 6 month -$223.00K.
| Period end | Increase (Decrease) in Accounts Receivable 6 month |
|---|---|
| 2023-06-30 | $22.66M 10-Q · filed 2023-08-08 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2016-06-30 | $735.00K 10-Q · filed 2016-08-11 |
| 2015-06-30 | -$223.00K 10-Q · filed 2016-08-11 |